Does thrombolysis for pulmonary embolism reduce the risk of chronic complications?


Journal

Acute medicine
ISSN: 1747-4892
Titre abrégé: Acute Med
Pays: England
ID NLM: 101553725

Informations de publication

Date de publication:
2021
Historique:
entrez: 22 3 2021
pubmed: 23 3 2021
medline: 25 3 2021
Statut: ppublish

Résumé

We assessed the efficacy of thrombolysis in avoiding long-term complications. Notes of patients thrombolysed for PE in the 2-year period were reviewed. The initial CTPA and echocardiogram results before thrombolysis were compared to the results of follow up imaging repeated after 6 months. Twenty-two patients were thrombolysed for PE. 14 patients had sub-massive PE and 8 patients had massive PE. The right ventricle (RV) was dilated on pre-thrombolysis echocardiogram in 16 patients. On follow up echocardiography all patients with massive PE (6 studies) had a normal RV size, with pulmonary artery pressures (PAP) of 29mmHg. Follow up echocardiography of patients with submassive PE (13 studies) showed 11 patients with a normal RV, with PAP of 28 mmHg.

Identifiants

pubmed: 33749690

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15-17

Auteurs

C Apsey (C)

Internal Medicine, University Hospital Lewisham Lewisham and Greenwich National Health Service Trust, London.

M Jawad (M)

Acute Internal Medicine, East Surrey Hospital, Surrey and Sussex Healthcare National Health Service Trust, Redhill.

M Daschel (M)

Acute Internal Medicine, East Surrey Hospital, Surrey and Sussex Healthcare National Health Service Trust, Redhill.

D Woosey (D)

Acute Internal Medicine, East Surrey Hospital, Surrey and Sussex Healthcare National Health Service Trust, Redhill.

C Limb (C)

Acute Internal Medicine, East Surrey Hospital, Surrey and Sussex Healthcare National Health Service Trust, Redhill.

M Wilde (M)

Acute Internal Medicine, East Surrey Hospital, Surrey and Sussex Healthcare National Health Service Trust, Redhill.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH